StoxAnupam Rasayan India vs Swan Corp: share price & financials comparison
NSE: ANURAS vs SWANCORP · Chemicals · as of 13 Nov 2026
Both prices rebased to 100 at the start of the selected period.
Anupam Rasayan India vs Swan Corp at a glance
Anupam Rasayan India (ANURAS) has a market capitalisation of ₹14,807 Cr, against ₹7,288 Cr for Swan Corp (SWANCORP). Over the past year Anupam Rasayan India has returned +21.0%, compared with -48.9% for Swan Corp. On valuation, Swan Corp trades at a lower P/E of 9.9 versus 82.1. Swan Corp earns a higher return on equity (9.5% vs 3.6%). Anupam Rasayan India comes out ahead on momentum and technicals. Swan Corp comes out ahead on size, valuation, profitability and financial health. Across the scored metrics below, Anupam Rasayan India leads on 8 and Swan Corp on 8. On StoxGud's 10-point checklist, Anupam Rasayan India scores 5/10 and Swan Corp scores 4/10.
| Metric | Anupam Rasayan India | Swan Corp |
|---|---|---|
| Size | ||
| Market cap | ₹14,807 Cr | ₹7,288 Cr |
| Revenue (latest FY) | ₹2,365 Cr | ₹4,371 Cr |
| Net profit (latest FY) | ₹170 Cr | ₹274 Cr |
| Valuation | ||
| P/E | 82.1 | 9.9 |
| P/B | 2.93 | 0.94 |
| Dividend yield | 0.10% | 0.04% |
| Profitability | ||
| Return on equity | 3.6% | 9.5% |
| Net profit margin | 6.9% | 18.0% |
| Operating margin | 23.5% | -6.0% |
| Growth | ||
| Revenue growth (YoY) | +10.2% | -8.1% |
| Net profit growth (YoY) | +12.7% | — |
| Revenue CAGR (multi-year) | +23.9% | +68.6% |
| Financial health | ||
| Debt to equity | 0.49 | 0.25 |
| Momentum | ||
| 1-month return | +11.6% | -12.6% |
| 1-year return | +21.0% | -48.9% |
| 3-year CAGR | +12.3% | -18.5% |
| 5-year CAGR | +9.5% | +13.3% |
| 10-year CAGR | — | +5.7% |
| Distance from 52W high | -5.5% | -51.2% |
| Technicals | ||
| RSI (14) | 83 | 44 |
| Price vs 200-day avg | +3.9% | -27.4% |
Highlighted cells lead on that metric. Market cap, revenue and RSI are shown for context and not scored.
10-point checklist side by side
| Check | Anupam Rasayan India | Swan Corp |
|---|---|---|
| Price above 50-day average | ✓ | ✗ |
| Price above 200-day average | ✓ | ✗ |
| 50-day average above 200-day (uptrend) | ✗ | ✗ |
| RSI in healthy 40–70 zone | ✗ | ✓ |
| Positive 1-year return | ✓ | ✗ |
| Return on equity above 15% | ✗ | ✗ |
| Debt to equity below 1 | ✓ | ✓ |
| Revenue growing year on year | ✓ | ✗ |
| Net profit margin above 10% | ✗ | ✓ |
| P/E below industry median | ✗ | ✓ |
| Score | 5/10 | 4/10 |
A rules-based screen for education only — not a buy or sell recommendation.
FAQs
Which is bigger, Anupam Rasayan India or Swan Corp?
Anupam Rasayan India has a market cap of ₹14,807 Cr and Swan Corp has a market cap of ₹7,288 Cr as of 13 Nov 2026.
Which has a lower P/E, Anupam Rasayan India or Swan Corp?
Swan Corp has the lower P/E: Anupam Rasayan India trades at 82.1 and Swan Corp at 9.9.
Which gave better returns in the last year, Anupam Rasayan India or Swan Corp?
Anupam Rasayan India did better: Anupam Rasayan India returned +21.0% and Swan Corp returned -48.9% over one year.
What is the difference between Anupam Rasayan India and Swan Corp?
Both are NSE-listed companies in Chemicals. Anupam Rasayan India is about 2.0 times the size of Swan Corp by market cap. In the latest financial year Anupam Rasayan India reported revenue of ₹2,365 Cr and Swan Corp ₹4,371 Cr. Operating margin is 23.5% for Anupam Rasayan India and -6.0% for Swan Corp. Debt to equity is 0.49 for Anupam Rasayan India and 0.25 for Swan Corp.
Which is better, Anupam Rasayan India or Swan Corp?
It depends on what you are looking for, and StoxGud does not recommend either stock. On the metrics compared above, Anupam Rasayan India leads on 8 and Swan Corp on 8. Anupam Rasayan India is ahead on momentum and technicals. Swan Corp is ahead on size, valuation, profitability and financial health. On StoxGud's rules-based checklist Anupam Rasayan India scores 5/10 and Swan Corp scores 4/10. This is information, not advice: consult a SEBI-registered adviser before investing.